Article Details
Retrieved on: 2021-10-30 16:44:21
Tags for this article:
Click the tags to see associated articles and topics
Excerpt
It is a monoclonal antibody that preferentially attacks toxic amyloid-beta oligomers (AOs) for the cure of early Alzheimer's disease.
Article found on: stockstelegraph.com
This article is found inside other hiswai user's workspaces. To start your own collection, sign up for free.
Sign UpAlready have an account? Log in here